These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4009285)

  • 1. Pancreas accumulation of radioiodinated HIPDM in mice and rats.
    Yamamoto K; Som P; Srivastava SC; Meinken GE; Brill AB
    J Nucl Med; 1985 Jul; 26(7):765-9. PubMed ID: 4009285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases.
    Kubota K; Som P; Brill AB; Sacker DF; Meinken GE; Srivastava SC; Atkins HL
    J Nucl Med; 1989 Nov; 30(11):1848-55. PubMed ID: 2509648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation and metabolism of [125I]HIPDM in the rat pancreas.
    Saji H; Kuge Y; Tsutsumi D; Yamamoto K; Konishi J; Yokoyama A
    Ann Nucl Med; 1991 Nov; 5(4):157-61. PubMed ID: 1797071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of radioiodinated L-alpha-methyltyrosine in pancreas of mice: concise communication.
    Tisljar U; Kloster G; Ritzl F; Stöcklin G
    J Nucl Med; 1979 Sep; 20(9):973-6. PubMed ID: 536844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine.
    Kung HF; Tramposch KM; Blau M
    J Nucl Med; 1983 Jan; 24(1):66-72. PubMed ID: 6401325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension.
    Shih WJ; Cottrill CM; Coupal JJ; O'Connor W; Kung HF; Ryo UY
    J Nucl Med; 1990 May; 31(5):668-73. PubMed ID: 2341903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreas scintigraphy using iodine-123-labeled HIPDM and SPECT.
    Yamamoto K; Shibata T; Saji H; Kubo S; Aoki E; Fujita T; Yonekura Y; Konishi J; Yokoyama A
    J Nucl Med; 1990 Jun; 31(6):1015-9. PubMed ID: 2189959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the human.
    Holman BL; Lee RG; Hill TC; Lovett RD; Lister-James J
    J Nucl Med; 1984 Jan; 25(1):25-30. PubMed ID: 6610030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental increase in brain HIPDM uptake by hypercapnia.
    Karatzas ND; Sfakianakis GN; Pappas D; Duncan R; Heal A; Serafini A; Kung HF
    J Nucl Med; 1988 Oct; 29(10):1675-82. PubMed ID: 3262727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of the metabolism and imaging of the lung in the patients with chronic obstructive pulmonary diseases using 131I-HIPDM].
    Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):282-4, 319. PubMed ID: 1306411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [iodine-125]N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3- propanediamine lung uptake using an isolated-perfused lung model.
    Slosman DO; Brill AB; Polla BS; Alderson PO
    J Nucl Med; 1987 Feb; 28(2):203-8. PubMed ID: 3806224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [123I]HIPDM pulmonary imaging demonstrates elastase-induced pulmonary emphysema.
    Shih WJ; Lai YL; Coupal JJ; Simmons G
    Lung; 1993; 171(1):31-41. PubMed ID: 8416418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of 131I-HIPDM in the patients with chronic obstructive pulmonary disease.
    Liu CT; Wang NQ; Oliaro A; Tian JH; Wang DL
    Panminerva Med; 1994 Sep; 36(3):124-7. PubMed ID: 7877825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 125I-HIPDM for studying tissue response due to toxic effects of cyclosporin-A in rats.
    Owunwanne A; Shihab-Eldeen A; Sadek S; Yacoub T; Hussain A; Abdel-Dayem HM
    Int J Rad Appl Instrum B; 1990; 17(5):507-9. PubMed ID: 2391246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal evolution of brain distribution of IMP and HIPDM. Concise communication.
    Moretti JL; Kung HF; Cesaro P; Blau M; Defer G; Holman L; Vigneron N; Rapin JR
    Nucl Med Commun; 1987 Jul; 8(7):597-602. PubMed ID: 3500438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and kinetic considerations in the use of [125I]HIPDM for quantitative measurement of regional cerebral blood flow.
    Lucignani G; Nehlig A; Blasberg R; Patlak CS; Anderson L; Fieschi C; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):86-96. PubMed ID: 3871785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats.
    Albright RE; Friedman AH; Fram EK; Harbury OL; Molter BA; Skatoff JH; Harris CC; Coleman RE; Drayer BP
    Stroke; 1988 Nov; 19(11):1404-10. PubMed ID: 3188125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial tumors: unexpected uptake of I-123 HIPDM.
    McVeigh MC; Merchut MP; Karesh SM; Ghobrial MW; Dillehay GL
    Radiology; 1986 Nov; 161(2):409-11. PubMed ID: 3763910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new, well-retained myocardial imaging agent: radioiodinated 15-(p-lodophenyl)-6-tellurapentadecanoic acid.
    Goodman MM; Knapp FF; Callahan AP; Ferren LA
    J Nucl Med; 1982 Oct; 23(10):904-8. PubMed ID: 7119885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the lung uptake of iodine-131 HIPDM by the single-pass multiple indicator dilution technique in a rabbit model.
    Abrams DN; Man SF; Noujaim AA
    J Nucl Med; 1987 Apr; 28(4):487-94. PubMed ID: 3553460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.